Literature DB >> 4286889

Biophysical studies of vesicular stomatitis virus.

R M McCombs, M B Melnick, J P Brunschwig.   

Abstract

McCombs, Robert M. (Baylor University College of Medicine, Houston, Tex.), Matilda Benyesh-Melnick, and Jean P. Brunschwig. Biophysical studies of vesicular stomatitis virus: J. Bacteriol. 91:803-812. 1966.-The infectivity and morphology of vesicular stomatitis virus (VSV) were studied after density gradient centrifugation in cesium chloride (CsCI), potassium tartrate (KT), and sucrose. Centrifugation in CsCl revealed two equally infectious bands corresponding to densities of 1.19 and 1.22 g/ml, and a third (density, 1.26 g/ml) band of low infectivity. Two bands (densities of 1.16 and 1.18 g/ml) were observed in the KT gradient, in which the lighter band contained most of the infectivity. Centrifugation in sucrose resulted in a single broad infectious band (density, 1.16 g/ml). The typical rod-shaped VSV particles were found mainly in the lighter bands obtained in CsCl (1.19 g/ml) and KT (1.16 g/ml) and in the single sucrose gradient band (1.16 g/ml). Bent particles equally as infectious as the rod-shaped particles were a constant finding in the CsCl preparations, and were observed mainly in the second band (density, 1.19 g). Numerous strands 15mmu wide were found in the third CsCl (density, 1.26 g/ml) and the second KT (1.18 g/ml) bands. Similar strands could be liberated from VSV particles after treatment with deoxycholate. Internal transverse striations were found to be a regular feature of VSV particles examined with the pseudoreplication negative-staining technique. For crude virus stocks, the physical particle-to-infectivity ratio ranged from 73 to 194. Several morphological similarities between VSV and myxoviruses were observed, including 10 mmu surface projections, pleomorphic morphological forms, and 15 mmu seemingly nucleoprotein strands.

Entities:  

Mesh:

Year:  1966        PMID: 4286889      PMCID: PMC314933          DOI: 10.1128/jb.91.2.803-812.1966

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  12 in total

1.  STUDIES ON HUMAN LEUKEMIA. II. STRUCTURE AND QUANTITATION OF MYXOVIRUS-LIKE PARTICLES ASSOCIATED WITH HUMAN LEUKEMIA.

Authors:  K O SMITH; M BENYESH-MELNICK; D J FERNBACH
Journal:  J Natl Cancer Inst       Date:  1964-09       Impact factor: 13.506

2.  A POSSIBLE MORPHOLOGIC BASIS FOR THE AUTOINTERFERENCE PHENOMENON IN VESICULAR STOMATITIS VIRUS.

Authors:  A J HACKETT
Journal:  Virology       Date:  1964-09       Impact factor: 3.616

3.  FORM OF THE NUCLEOPROTEIN COMPONENT AS A TAXONOMIC CRITERION FOR THE MYXOVIRUSES.

Authors:  A P WATERSON; J G CRUICKSHANK
Journal:  Nature       Date:  1964-02-08       Impact factor: 49.962

4.  THE EFFECT OF TRYPSIN ON INFLUENZA VIRUS.

Authors:  L BORECKY; V LACKOVIC; E MIRENA
Journal:  Acta Virol       Date:  1964-11       Impact factor: 1.162

5.  Electron microscopic counting of virus particles by sedimentation on aluminized grids.

Authors:  K O SMITH; J L MELNICK
Journal:  J Immunol       Date:  1962-08       Impact factor: 5.422

6.  A method for staining virus particles and identifying their nucleic acid type in the electron microscope.

Authors:  K O SMITH; J L MELNICK
Journal:  Virology       Date:  1962-07       Impact factor: 3.616

7.  Factors influencing enterovirus and reovirus growth and plaque formation.

Authors:  C WALLIS; J L MELNICK; M BIANCHI
Journal:  Tex Rep Biol Med       Date:  1962

8.  The effect of trypsin on representative myxoviruses.

Authors:  I GRESSER; J F ENDERS
Journal:  Virology       Date:  1961-04       Impact factor: 3.616

9.  [Electron microscopic research on the virus of vesicular stomatitis].

Authors:  E RECZKO
Journal:  Arch Gesamte Virusforsch       Date:  1961

10.  The development and structure of vesicular stomatitis virus.

Authors:  A F HOWATSON; G F WHITMORE
Journal:  Virology       Date:  1962-04       Impact factor: 3.616

View more
  43 in total

1.  A cellular function can enhance gene expression and plating efficiency of a mutant defective in the gene for ICP0, a transactivating protein of herpes simplex virus type 1.

Authors:  W Cai; P A Schaffer
Journal:  J Virol       Date:  1991-08       Impact factor: 5.103

2.  Vesicular stomatitis virus causes abortion and neonatal death in ferrets.

Authors:  S C Suffin; K B Muck; D D Porter
Journal:  J Clin Microbiol       Date:  1977-10       Impact factor: 5.948

3.  Photodynamic treatment of herpes simplex virus during its replicative cycle.

Authors:  N C Khan; J L Melnick; N Biswal
Journal:  J Virol       Date:  1977-01       Impact factor: 5.103

4.  Further characterization of infectious hematopoietic necrosis virus of salmonid fish (Oregon strain).

Authors:  P E McAllister; J L Fryer; K S Pilcher
Journal:  Arch Gesamte Virusforsch       Date:  1974

5.  [Genetic material of herpesviruses. II. Genetic relatedness of various herpesviruses].

Authors:  H Ludwig
Journal:  Med Microbiol Immunol       Date:  1972       Impact factor: 3.402

6.  Replication of the Moloney murine sarcoma-leukemia virus in XC cells.

Authors:  S T Trowbridge; M Benyesh-Melnick; N Biswal
Journal:  J Virol       Date:  1973-01       Impact factor: 5.103

7.  Comparative biophysical studies of hepatitis B antigen, subtypes adw and ayw.

Authors:  R Chairez; F B Hollinger; J P Brunschwig; G R Dreesman
Journal:  J Virol       Date:  1975-01       Impact factor: 5.103

8.  Lipid composition of purified vesicular stomatitis viruses.

Authors:  J J McSharry; R R Wagner
Journal:  J Virol       Date:  1971-01       Impact factor: 5.103

9.  Effects of actinomycin D and ultraviolet and ionizing radiation on Pichinde virus.

Authors:  M F Carter; F A Murphy; J P Brunschwig; C Noonan; W E Rawls
Journal:  J Virol       Date:  1973-07       Impact factor: 5.103

10.  Analysis of virion associated host proteins in vesicular stomatitis virus using a proteomics approach.

Authors:  Megan Moerdyk-Schauwecker; Sun-Il Hwang; Valery Z Grdzelishvili
Journal:  Virol J       Date:  2009-10-12       Impact factor: 4.099

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.